This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Tzelepi C. Vasiliki, Gogadis T. Aristeidis, Adamidis K. Christos et al, The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast Cancer. Forum ClinOncol 2019 10(2): 2–14.VasilikiTzelepi C.AristeidisGogadis T.ChristosAdamidis K.The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast CancerForum ClinOncol201910221410.2478/fco-2019-0007Search in Google Scholar
Amrallah A. Mohammed, Hanna M. Ibrahim, Hanna A. Atwa et al, Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia. Forum ClinOncol 2019 10(2): 15–25.MohammedAmrallah A.IbrahimHanna M.AtwaHanna A.Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasiaForum ClinOncol2019102152510.2478/fco-2019-0005Search in Google Scholar
